Showing 21-30 of 300 results for "".
Tactics for Effective Communication With Patients
https://modernod.com/topics/business/tactics-for-effective-communicationwith-patients/37948/Fine-tuning your communication skills can lead to better outcomes through increased compliance.Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment
https://modernod.com/programs/cme/Consensus-Panel-Highlights-Pharmacotherapy-for-Presbyopia-and-Considerations-for-the-Posterior-Segment/36580/This supplement summarizes a panel discussion among optometrists and retina specialists who convened to discuss the expanding armamentarium of presbyopia-correcting eye drops and establish a set of best practices regarding diagnostic testing, patient candidacy, and follow-up regimens.Clinical Case Compendium: A Journey Through Detection, Treatment Initiation, and 2 Years of Active Complement Inhibition
https://modernod.com/articles/geographic-atrophy-case-compendium/a-journey-through-detection-treatment-initiation-and-2-years-of-active-complement-inhibition/39245/Commotio Retinae in a Teenager
https://modernod.com/topics/retina/commotio-retinae-in-a-teenager/39026/Advice on the clinical management of patients who develop this transient opacification of the retina after experiencing blunt ocular trauma.GA Case Compendium: Challenges in Patient Education and Treatment Decision-Making for Geographic Atrophy
https://modernod.com/articles/geographic-atrophy-case-compendium/challenges-in-patient-education-and-treatment-decision-making-for-geographic-atrophy/39853/Updates in Keratoconus Management and the FDA-Approved iLink Cross-Linking Procedure
https://modernod.com/mod-issues/supplements-inserts/updates-in-keratoconus-management-and-the-fda-approved-ilink-cross-linking-procedure/38254/Optometrists play an integral role in early diagnosis and intervention.New MIGS Approach for Glaucoma Patients
https://modernod.com/articles/significant-findings/new-migs-approach-for-glaucoma-patients/39852/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuThe OmniVu™ Lens System
https://modernod.com/articles/visionary-breakthroughs/the-omnivusupsup-lens-system/39820/Atia Vision designs a “no-compromise” PC-IOL.Ready to Embrace the Newest Dry Eye Drop?
https://modernod.com/articles/significant-findings/ready-to-embrace-the-newest-dry-eye-drop/37850/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat2025: A Year of Presbyopia Promise
https://modernod.com/articles/significant-findings/2025-a-year-of-presbyopia-promise/37845/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curat